We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleComplementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib.AuthorsHunt, R H; Harper, S; Callegari, P; Yu, C; Quan, H; Evans, J; James, C; Bowen, B; Rashid, FAbstractCyclo-oxygenase-2-selective non-steroidal anti-inflammatory drugs are intended to preserve cyclo-oxygenase-1-mediated gastroprotection and platelet function, whilst inhibiting cyclo-oxygenase-2-mediated inflammation.PublicationAlimentary pharmacology & therapeutics, 2003, Vol 17, Issue 2, p201ISSN0269-2813Publication typeJournal ArticleDOI10.1046/j.1365-2036.2003.01407.x